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Many respiratory viruses are mainly responsible for common
cold, bronchitis, bronchiolitis, and pneumonia. Furthermore,
asthma and chronic obstructive pulmonary disease (COPD) are
major cause of mortality. The prevalence of asthma in developed
countries is approximately 10% in adults and even higher in chil-
dren (Barnes, 2008). Thus, the medical costs for these diseases are
a major burden in many countries. Respiratory virus infections
also cause the most of acute exacerbation of asthma (virus-
induced asthma) or COPD. Among them, human rhinoviruses
(HRV) are detected in the two thirds of the cases with asthma
exacerbations in children (Johnston et al., 1995). However, epi-
demiology and pathophysiology of asthma and COPD is not
known. Furthermore, a few effective vaccines have been applied.
Therefore, it may be important to better understand pathophys-
iology of virus-induced asthma or virus-induced COPD exacer-
bation. Both aspects of the virus agents and host defense systems
including acute/chronic inflammation and airway tissue remod-
eling should be clarified. This e-book aims to review and discuss
pathophysiology and epidemiology of virus-induced asthma and
COPD focusing on new findings of the host immunity and
virology.
This Research Topic contains 7 review articles and 3 origi-
nal articles regarding pathophysiology of virus-induced asthma.
As the first article, Kudo et al. (2013) reviewed pathology of
asthma. This article globally covers from molecular histopathol-
ogy involved in cytokine networks of asthma. The readers may
easily understand molecular immunopathology of virus-induced
asthma. In the second issue, Okayama (2013) presents cellu-
lar and humoral immunity of asthma. Accumulating evidence
implicates that the genetic and environmental factors may be
associated with virus-induced asthma. This work focuses on
the immunological mechanisms that may explain why asthma
is associated with RSV-and HRV-infection. As the third review
article, Kimura et al. (2013) present the molecular mechanisms
between various cytokines and innate immunity of viral respi-
ratory infections including virus-induced asthma. The authors
also show the signaling pathways with regard to them. In the 4th
review article, Tsukagoshi et al. (2013) discuss the genetic char-
acteristics and molecular evolution of respiratory viruses, and
epidemiology of asthma. They also show phylogenetic analysis
of the detected viruses in the children with respiratory syncy-
tial virus- (RSV) and/or HRV-associated wheezing and asthma.
As the 5th review article, Inoue and Shimojo (2013) present
epidemiology and pathophysiology of virus-induced asthma in
children. They summarize the previous findings and discuss how
clinicians can effectively intervene in these viral infections to pre-
vent the development of asthma. Next, Kurai et al. (2013) and
Saraya et al. (2014) present pathophysiology of virus-induced
COPD and asthma in adults. They summarize current knowl-
edge concerning exacerbation of both COPD and asthma by
focusing on the clinical significance of associated respiratory
virus infections. Furthermore, influenza A(H1N1)pdm09 virus
have suddenly emerged in Mexico in the spring, 2009. The
virus can cause influenza pandemy accompanying with pneumo-
nia/wheezing. Obuchi et al. (2013) review essential reports with
regard to asthma in patients infected with the virus, and they
discuss the utility of influenza vaccines and antivirals. Although
HPIV3 is an etiological agent for respiratory disorders such as
pneumonia and asthma, there is no prophylactic human vaccine
against the virus infection. In the 9th issue as original article,
Senchi et al. (2013) present the development of an oligomannose-
coated liposome (OML) nasal vaccine against HPIV3 in combi-
nation with an effective adjuvant Poly(I:C). They report that their
newly-developed vaccine can successfully induce antigen-specific
immunity with a small amount of antigen via the nasal route.
These results highlight the utility of combining sophisticated sys-
tems in the development of a novel vaccine against HPIV3. In
the final article, Matsunaga et al. (2014) present the develop-
ment of monoclonal antibodies (MAbs) against hemagglutinin-
neuraminidase (HN) of HPIV3. For synthesizing the antigen
protein, they utilized the wheat germ cell-free system. This new
cell-free system-based protocol for antigen production enabled to
create the MAbs that can be applicable in various immune assays
such as flowcytometry and immunoprecipitation analyses. The
newly-developedMAbs could thus be a valuable tool for the study
of HPIV3 infection as well as the several diagnostic tests of this
virus.
In conclusion, we believe that these works are well summa-
rized and informative to glimpse the field of virus-associated
asthma/COPD, and may help understanding the basic and clin-
ical aspects of the disease. We would be happy if this collection
of papers will offer new stimuli and perspectives for not only
researchers but also clinicians working around the exciting and
emerging the e-book.
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